KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Change in Cash (2016 - 2026)

Halozyme Therapeutics has reported Change in Cash over the past 17 years, most recently at $175.6 million for Q1 2026.

  • Quarterly Change in Cash rose 190.33% to $175.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $135.7 million through Mar 2026, up 1059.57% year-over-year, with the annual reading at $20.6 million for FY2025, 916.31% up from the prior year.
  • Change in Cash was $175.6 million for Q1 2026 at Halozyme Therapeutics, up from -$283.2 million in the prior quarter.
  • Over five years, Change in Cash peaked at $357.8 million in Q3 2025 and troughed at -$283.2 million in Q4 2025.
  • The 5-year median for Change in Cash is $23.2 million (2024), against an average of $11.3 million.
  • Year-over-year, Change in Cash plummeted 15489.59% in 2023 and then skyrocketed 1166.61% in 2025.
  • A 5-year view of Change in Cash shows it stood at $87.0 million in 2022, then plummeted by 279.07% to -$155.9 million in 2023, then skyrocketed by 75.32% to -$38.5 million in 2024, then tumbled by 636.31% to -$283.2 million in 2025, then skyrocketed by 161.99% to $175.6 million in 2026.
  • Per Business Quant, the three most recent readings for HALO's Change in Cash are $175.6 million (Q1 2026), -$283.2 million (Q4 2025), and $357.8 million (Q3 2025).